Skip to main content
All lobbying filings

Fresenius Medical Care North America

Fresenius Medical Care North America filed a Q4 report for Fresenius Medical Care North America on January 16, 2026.

Lobbying for Fresenius Medical Care North America

As filed: FRESENIUS MEDICAL CARE NORTH AMERICA for FRESENIUS MEDICAL CARE NORTH AMERICA.

All filings by Fresenius Medical Care North America · Everything Fresenius Medical Care North America has reported

 Filing · LD-2 quarterly report Q4 report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 16, 2026
Expenses
$1,220,000
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
District of Columbia

Official filing document

 Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 2

H.R. 2199/S. 1173- Restore Protections for Dialysis Patients Act Implementation of the "One Big, Beautiful Bill" Act.-P.L. 119-21 The VA/MILCON Appropriations Subcommittee bill. H.R. 6214/S. 2730 - Kidney Care Access Protection Act Medicare and Medicaid coverage End Stage Renal Disease (ESRD) Prospective Payment System (PPS) Kidney Care Choices Model and Skin Substitutes

 Bills named in this filing 4
  • H.R. 2199
    Restore Protections for Dialysis Patients Act
  • S. 1173
    Restore Protections for Dialysis Patients Act
  • H.R. 6214
    Kidney Care Access Protection Act
  • S. 2730
    Kidney Care Access Protection Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem